卡姆丹克太陽能(00712.HK)2019年度淨虧損收窄至1.22億元
格隆匯3月31日丨卡姆丹克太陽能(00712.HK)公佈,截至2019年12月31日止年度,實現收益9300萬元(人民幣,下同),同比下降46.1%;毛損約120萬元;公司擁有人應占淨虧損1.22億元,同比下降32.1%;每股虧損21.56分。
收益下降主要由於上游太陽能晶片及晶錠的售價及銷量同告下跌,鋰電池及儲電系統業務的收益亦有所減少,但跌幅因銷售多晶硅帶來的收益及下游太陽能業務帶來的收益增加而局部緩和。期內市場繼續存在過盛產能及政府頒佈不利政策。此行業環境為國內的太陽能市場製造不明朗因素,衝擊上游產品的行業需求及售價。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.